Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hodgkin Disease 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 59 fludarabine phosphate 52 Peripheral Blood Stem Cell Transplantation 40 Busulfan 39 Tacrolimus 35 Antilymphocyte Serum 34 Mycophenolic Acid 33 Radiotherapy 30 Filgrastim 28 Cyclosporine 25 Melphalan 24 Methotrexate 22 Whole-Body Irradiation 21 fludarabine 20 Methylprednisolone 17 Etoposide 16 Cord Blood Stem Cell Transplantation 15 sargramostim 9 Rituximab 9 Granulocyte Colony-Stimulating Factor 9 Cytarabine 9 Bortezomib 9 Alemtuzumab 9 Sirolimus 8 Epoetin Alfa 7 Psychiatric Rehabilitation 6 Prednisone 6 Flow Cytometry 6 Carmustine 6 Trimethoprim, Sulfamethoxazole Drug Combination 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Enteral Nutrition × Lymphoid × Clear all

NCT04703985 2023-12-07

GAGNE

University Hospital, Bordeaux

LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡